2022 open day in the University of Milan: An opportunity for HCV screening

Aldinio, Giovanni; D’Ambrosio, Roberta; Perrone, Pier Mario; Castaldi, Silvana

doi:10.1111/liv.15505

Cited by 2 publications

(4 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only one study reported no anti-HCV detection in a point-of-care test-based study conducted in 291 subjects attending a university open-day and aged 20 years. 73 According to published studies, 54%-88% of seropositive individuals were already aware of their status (Table 4; Table S1).…”

Section: [France Belgium the Netherlands Luxembourg Germany Switzerla...mentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of HCV infection in Europe in the DAA era: Review

D'Ambrosio,

Anolli,

Pugliese

et al. 2024

Liver International

Self Cite

View full text Add to dashboard Cite

In 2016, the Global Health Sector Strategy, ratified by the 69th World Health Assembly, set the ambitious goal of eliminating hepatitis C virus (HCV) and hepatitis B virus infections by 2030, emphasizing the importance of national screening programmes. Achieving this goal depends on each country's ability to identify and treat 80% of chronic hepatitis C cases, a critical threshold set by the World Health Organization. Traditionally, estimates of HCV prevalence have been based on interferon era studies that focused on high‐risk subgroups rather than the general population. In addition, the incomplete data available from national registries also limited the understanding of HCV prevalence. The 2016 report from the European Centre for Disease Prevention and Control highlighted that HCV rates varied across European counties, ranging from .1% to 5.9%. However, data were only available for 13 countries, making the overall picture less clear. Additionally, the epidemiological data may have underestimated the true burden of HCV due to lack of awareness among those with chronic infection. The main objective of this review is to provide a comprehensive summary of HCV epidemiology in Europe in the current era of direct‐acting antivirals (DAAs). The data included in the analysis range from the end of 2013 to December 2023 and have been categorised according to the United Nations Geoscheme. The resulting synthesis underscores the noteworthy impact of DAA treatment on the epidemiological situation.

show abstract

Section: [France Belgium the Netherlands Luxembourg Germany Switzerla...mentioning

confidence: 99%

“…According to them, anti‐HCV prevalence in the general population ranged from .23% to 8.96% (Table 4; Figure 1). Only one study reported no anti‐HCV detection in a point‐of‐care test‐based study conducted in 291 subjects attending a university open‐day and aged 20 (18–79) years 73 …”

Section: Southern Europementioning

confidence: 99%

Prevalence of HCV infection in Europe in the DAA era: Review

D'Ambrosio,

Anolli,

Pugliese

et al. 2024

Liver International

Self Cite

View full text Add to dashboard Cite

show abstract

“…What we learned from these studies is that opportunistic screening programmes represent a highly valuable occasion to screen general population and have high grade of acceptability. [1][2][3][4] At the time of writing, a national HCV screening involving people born between 1969 and 1989 is ongoing in Italy. This age target was chosen after a costeffectiveness evaluation conducted in 2020, which supported a graduated birth cohort approach.…”

Section: Opportunistic Hcv Screening In the General Population: New I...mentioning

confidence: 99%

“…Dear Editor, We read with interest the letter by Aldinio et al 1 in which the authors, in response to our previous report 2 regarding an opportunistic HCV and SARS-CoV-2 co-screening, reported their experience of HCV point-of-care testing offered to the general population during the 2022 Open Day of the University of Milan, with most participants (217/292) born >1989. Taking advantages of mass serological screening 3 and the COVID-19 vaccination campaign, 4 HCV screening programmes have been conducted in Italy since the start of COVID-19 pandemic, targeting different layers of the general population.…”

Section: Opportunistic Hcv Screening In the General Population: New I...mentioning

confidence: 99%